THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Ensign Peak Advisors, Inc's Holding History (CIK: 0001454984)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 60,907 Value ($000) $573 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 60,907 Value ($000) $491 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 60,907 Value ($000) $516 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 60,907 Value ($000) $546 Avg Close $9.27 Range $8.21 - $11.71
Q4 2023
Shares 63,980 Value ($000) $719 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 63,980 Value ($000) $552 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 56,730 Value ($000) $587 Avg Close $11.04 Range $9.98 - $12.03
Q1 2023
Shares 56,730 Value ($000) $616 Avg Close $10.57 Range $9.25 - $11.52
Q4 2022
Shares 47,580 Value ($000) $534 Avg Close $10.51 Range $9.56 - $11.83
Q3 2022
Shares 24,830 Value ($000) $252 Avg Close $9.37 Range $7.53 - $11.00
Q2 2022
Shares 24,830 Value ($000) $225 Avg Close $9.21 Range $8.15 - $10.52
Q1 2022
Shares 24,830 Value ($000) $237 Avg Close $9.80 Range $7.71 - $13.17
Q4 2021
Shares 24,830 Value ($000) $274 Avg Close $8.72 Range $7.30 - $11.24
Q1 2020
Shares 6,081 Value ($000) $141 Avg Close $25.03 Range $16.86 - $31.54
Q4 2019
Shares 12,162 Value ($000) $315 Avg Close $19.43 Range $15.72 - $26.47